Juno Therapeutics Reports Fourth Quarter and 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Juno Therapeutics (JUNO) Misses Q4 EPS by 6c
February 29, 2016 4:05 PM ESTJuno Therapeutics (NASDAQ: JUNO) reported Q4 EPS of ($0.53), $0.06 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $4.15 million versus the consensus estimate of $4.79 million.
For earnings history and earnings-related data on Juno Therapeutics (JUNO) click here.
... More